Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
25% TCA vs 30% Salicylic Acid in Mild to Moderate Acne Vulgaris
NCT05712837Completed
- Sponsor
- Combined Military Hospital Abbottabad
- Start
- Jun 2022
- Primary completion
- Nov 2022
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in acne vulgaris comparing 25% TCA with 30% Salicylic Acid (2 arms). Primary endpoints: Michaelsson acne score at 12 weeks and Individual lesion counts at 12 weeks. Started Jun 2022; status: completed.
02
Drugs
trichloroacetic acidSalvax
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT05712837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05712837.